← Back to Clinical Trials
Recruiting NCT06612099

NCT06612099 Comparison of the Effects of Aerobic Exercise Training and Mat Pilates Exercise on Blood Pressure, Functional Capacity and Quality of Life in Hypertensive Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06612099
Status Recruiting
Phase
Sponsor Bezmialem Vakif University
Condition Hypertension
Study Type INTERVENTIONAL
Enrollment 27 participants
Start Date 2024-09-20
Primary Completion 2025-05-30

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Aerobic ExerciseMat Pilates Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 27 participants in total. It began in 2024-09-20 with a primary completion date of 2025-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The research aims to compare two different exercise approaches applied to hypertensive individuals. After completion of the research, it will be revealed which exercise approach is more effective on the parameters evaluated in hypertensive individuals. In this context, it is aimed to increase the use of the exercise approach, which is found to be more effective in hypertensive individuals, in the treatment program.

Eligibility Criteria

Inclusion Criteria: * Hypertension (blood pressure ≥ Individuals diagnosed with 85/135 mmHg) and under medical follow-up, * Volunteering to participate in the study, * Not having been included in any exercise program in the last 4 weeks. Exclusion Criteria: * Blood pressure Individuals with ≥ 110/180 mmHg, * Having had a cerebrovascular accident or cardiovascular disease in the last 6 months, * Having an orthopedic or neurological disorder that prevents walking. * Having serious cardiovascular/pulmonary disease.

Contact & Investigator

Central Contact

Çağla Yılmaz, BPT

✉ caglayillllmaz@gmail.com

📞 5370101901

Principal Investigator

Çağla Yılmaz, BPT

PRINCIPAL INVESTIGATOR

Bezmialem Vakif University

Frequently Asked Questions

Who can join the NCT06612099 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 70 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06612099 currently recruiting?

Yes, NCT06612099 is actively recruiting participants. Contact the research team at caglayillllmaz@gmail.com for enrollment information.

Where is the NCT06612099 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06612099 clinical trial?

NCT06612099 is sponsored by Bezmialem Vakif University. The principal investigator is Çağla Yılmaz, BPT at Bezmialem Vakif University. The trial plans to enroll 27 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology